Gene · 3945
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Upstream open reading frame-encoded MP31 disrupts the mitochondrial quality control process and inhibits tumorigenesis in glioblastoma. | Neuro Oncol | 2023 | 37280112 | PubTator, text mining | PubMed |
| Appropriate cold stimulation changes energy distribution to improve stress resistance in broilers. | J Anim Sci | 2023 | 37279534 | PubTator, text mining | PubMed |
| ULK1-mediated metabolic reprogramming regulates Vps34 lipid kinase activity by its lactylation. | Sci Adv | 2023 | 37267363 | PubTator, text mining | PubMed |
| Obesity contributes to hepatocellular carcinoma development via immunosuppressive microenvironment remodeling. | Front Immunol | 2023 | 37266440 | PubTator, text mining | PubMed |
| Screening of key functional components of Taohong Siwu Decoction on ischemic stroke treatment based on multiobjective optimization approach and experimental validation. | BMC Complement Med Ther | 2023 | 37264383 | PubTator, text mining | PubMed |
| Association of Self-Reported Nighttime Sleep Duration with Chronic Kidney Disease: China Health and Retirement Longitudinal Study. | Am J Nephrol | 2023 | 37253331 | PubTator, text mining | PubMed |
| Design and Synthesis of Thiazole Scaffold-Based Small Molecules as Anticancer Agents Targeting the Human Lactate Dehydrogenase A Enzyme. | ACS Omega | 2023 | 37251149 | PubTator, text mining | PubMed |
| Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies. | Signal Transduct Target Ther | 2023 | 37244925 | PubTator, text mining | PubMed |
| Extended Opioid Exposure Modulates the Molecular Metabolism of Clear Cell Renal Cell Carcinoma. | Life (Basel) | 2023 | 37240841 | PubTator, text mining | PubMed |
| Potential Role of the mTORC1-PGC1α-PPARα Axis under Type-II Diabetes and Hypertension in the Human Heart. | Int J Mol Sci | 2023 | 37239977 | PubTator, text mining | PubMed |
| Comprehensive Proteome and Acetyl-Proteome Atlas Reveals Hepatic Lipid Metabolism in Layer Hens with Fatty Liver Hemorrhagic Syndrome. | Int J Mol Sci | 2023 | 37239836 | PubTator, text mining | PubMed |
| Lactate mediated metabolic crosstalk between cancer and immune cells and its therapeutic implications. | Front Oncol | 2023 | 37234972 | PubTator, text mining | PubMed |
| The Relationship between Maternal Antibodies to Fetal Brain and Prenatal Stress Exposure in Autism Spectrum Disorder. | Metabolites | 2023 | 37233704 | PubTator, text mining | PubMed |
| Proximity labelling identifies pro-migratory endocytic recycling cargo and machinery of the Rab4 and Rab11 families. | J Cell Sci | 2023 | 37232246 | PubTator, text mining | PubMed |
| Modeling fibrotic alveolar transitional cells with pluripotent stem cell-derived alveolar organoids. | Life Sci Alliance | 2023 | 37230801 | PubTator, text mining | PubMed |
| Exercise metabolism and adaptation in skeletal muscle. | Nat Rev Mol Cell Biol | 2023 | 37225892 | PubTator, text mining | PubMed |
| Reprogramming of glucose metabolism via PFKFB4 is critical in FGF16-driven invasion of breast cancer cells. | Biosci Rep | 2023 | 37222403 | PubTator, text mining | PubMed |
| Microproteins: Overlooked regulators of physiology and disease. | iScience | 2023 | 37213226 | PubTator, text mining | PubMed |
| Cardiac toxicities in multiple myeloma: an updated and a deeper look into the effect of different medications and novel therapies. | Blood Cancer J | 2023 | 37208317 | PubTator, text mining | PubMed |
| A prediction model identifying glycolysis signature as therapeutic target for psoriasis. | Front Immunol | 2023 | 37205116 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3945/papers?page=22